SCHEMBL874093

SCHEMBL874093

CCCOc1cccc(OCBr)c1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
GPBAR1 Q8TDU6 1/20 0.49
CYSLTR1 Q9Y271 1/20 0.49
TSHR P16473 3/20 0.47
KDM4E B2RXH2 2/20 0.45
MAPK1 P28482 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
NR1H4 Q96RI1 1/20 0.42
DHFR P00374 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,3-Dipropoxybenzene SCHEMBL73716 0.89 KMT2A (0.63) KMT2AGPBAR1CYSLTR1TSHRKDM4E
SCHEMBL7614389 0.88 KMT2A (0.54) KMT2AGPBAR1CYSLTR1TSHRKDM4E
SCHEMBL1770370 0.85 TP53 (0.50) TSHRMAPK1LMNA
1-Ethoxy-3-Propoxybenzene SCHEMBL3459404 0.83 MAPK1 (0.59) KMT2AGPBAR1CYSLTR1TSHRKDM4E
SCHEMBL9487763 0.83 KMT2A (0.58) KMT2AGPBAR1CYSLTR1TSHRKDM4E
1-Butyloxy-3-Propoxybenzene SCHEMBL3390925 0.83 TSHR (0.59) KMT2AGPBAR1CYSLTR1TSHRMAPK1
SCHEMBL16973792 0.82 MAPK1 (0.50) TSHRKDM4EMAPK1CYP1A2CYP2D6
1-Propoxy-3-Pentoxybenzene SCHEMBL4568913 0.82 TSHR (0.68) KMT2AGPBAR1CYSLTR1TSHR
SCHEMBL10796629 0.82 KMT2A (0.61) KMT2AGPBAR1CYSLTR1TSHRMAPK1
1-Methoxy-3-Propoxybenzene SCHEMBL791921 0.82 MAPK1 (0.62) KMT2AGPBAR1CYSLTR1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP disclosed
WO-2012040258-A2 THERAPEUTIC PIPERAZINES HELICON THERAPEUTICS, INC. (US) 2012-03-29 WO disclosed